← Back to Search

ChiCAS for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Led By Scott D Rhodes, PhD
Research Sponsored by Centers for Disease Control and Prevention
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-identify as male-to-female transgender or report having been born male and identifying as female;
Self-identify as Hispanic or Latina;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up uptake compared to baseline assessed 6 months after completion of the intervention.
Awards & highlights

Study Summary

This trial will test if a locally developed, Spanish language small group behavioral intervention (ChiCAS) can promote HIV prevention among Hispanic/Latina transgender women who have sex with men.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~uptake compared to baseline assessed 6 months after completion of the intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and uptake compared to baseline assessed 6 months after completion of the intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Consistent condom use
Uptake of PrEP
Uptake of medically supervised hormone therapy

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait list comparison (control) armExperimental Treatment1 Intervention
Persons randomized to this arm will have completed the study consent process (including being tested with the INSTI rapid HIV test to verify their self-reported HIV negative status and their eligibility to participate in the study) and the baseline survey, but will not receive the Spanish language ChiCAS intervention until they complete a follow-up assessment 6 months after completing the baseline assessment.
Group II: Intervention armExperimental Treatment1 Intervention
Persons randomized to this arm will have completed the study consent process (including being tested with the INSTI rapid HIV test to verify their self-reported HIV negative status and their eligibility to participate in the study) and the baseline survey, and will receive the Spanish language ChiCAS intervention shortly after being randomized and will complete a follow-up assessment 6 months after completing the intervention. .
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ChiCAS
2019
N/A
~150

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionLead Sponsor
873 Previous Clinical Trials
22,467,436 Total Patients Enrolled
Scott D Rhodes, PhDPrincipal InvestigatorWake Forest University Health Sciences
4 Previous Clinical Trials
758 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~25 spots leftby Mar 2025